Get a Free 5ml Mini Now Free 5ml Mini With Every Order of The Mantle

MINOXIDIL OXOTHIAZOLIDINECARBOXYLATE.

Avoid / HAIR CONDITIONING, HAIR FIXING

MINOXIDIL OXOTHIAZOLIDINECARBOXYLATE is a derivative of Minoxidil, conceptually linked to promoting hair health and growth. Its precise efficacy and mechanism as an independent compound, however, are not extensively documented in available research.

Hair conditioning Hair fixing

Science

While the specific mechanism of action for MINOXIDIL OXOTHIAZOLIDINECARBOXYLATE lacks detailed description, its parent compound, Minoxidil, is known to operate by engaging adenosine triphosphate (ATP)-sensitive potassium channels within cell membranes. This activity stimulates localized microcirculation around hair follicles, induces arteriolar vasodilation, and extends the anagen (growth) phase while shortening the telogen (resting) phase of hair, alongside potential induction of vascular endothelial growth factor (VEGF) expression.


Research

Low confidence
Effective range N/A
Optimal

N/A


Transparency

Not commonly dusted

The Formula

Solubility
Unknown
Optimal pH N/A
0 7 14

Stability

Specific stability insights for MINOXIDIL OXOTHIAZOLIDINECARBOXYLATE are not available. For the parent compound, Minoxidil, formulations at concentrations between 2% and 15% have demonstrated stability for at least 180 days in a FOAMIL base under ambient conditions, maintaining pH and physical integrity. Minoxidil formulations are generally stable within pH ranges of 5.0-8.0, with stability also noted around pH 4.5.


Safety

CIR Status
Not reviewed
Sensitization risk High

MINOXIDIL OXOTHIAZOLIDINECARBOXYLATE carries significant regulatory restrictions, being classified as 'Regulated, Forbidden in Europe' and receiving a 'Strong penalty' across all categories by COSMILE Europe and INCI Beauty. No specific FDA approval for this derivative has been identified, differentiating it from the FDA-approved status of Minoxidil for topical hair loss treatments.


Your Skin

No Normal
No Dry
No Oily
No Sensitive
Irritancy High
Comedogenicity Unknown

Our Assessment

Avoid

Due to a lack of specific clinical efficacy data for MINOXIDIL OXOTHIAZOLIDINECARBOXYLATE, its classification as 'Forbidden in Europe,' and reported high irritancy, its inclusion in precision skincare formulations is strongly advised against.


Related

Finding similar ingredients…